MedTrace Logo

Preoperative Stereotactic Radiosurgery for Brain Metastases

NCT04503772 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-12-04

No results posted yet for this study

Summary

STEP is a French multicentre, prospective, non-randomized, phase II study designed to assess 6-months local control after pre-operative stereotactic radiosurgery (SRS) for patients with brain metastases

Conditions

Interventions

PROCEDURE

Preoperative SRS

Patient will be treat with preoperative SRS and then surgery for brain metastases is realized within 3 days.

Sponsors & Collaborators

  • Groupement Interrégional de Recherche Clinique et d'Innovation (AURA)

    collaborator UNKNOWN

  • Centre Jean Perrin

    lead OTHER

Principal Investigators

  • Lucie BRUN, MD · Centre Jean Perrin

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-04
Primary Completion
2025-05-19
Completion
2025-11-25

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04503772 on ClinicalTrials.gov